An international Delphi panel of 53 experienced endoscopists from 16 countries has proposed standardized practices for confirming complete removal of…
Browsing: Clinical Updates
EviCore by Evernorth will add Guardant Health’s Shield blood test to its colorectal cancer screening coverage starting January 1, 2027,…
Five-year follow-up from the PROFILE randomized trial found that starting anti-TNF therapy immediately after diagnosis was associated with substantially better…
An Epic Research analysis of 11,469 adults ages 18–44 found that very low liver enzyme levels were associated with a…
A global risk-attribution analysis suggests that exposure to Helicobacter pylori may be associated with 22% of colorectal cancer cases worldwide.…
The FDA has cleared a clinical trial at the University of Colorado Anschutz testing an experimental CAR T-cell therapy in…
A retrospective study of 383 patients undergoing bariatric surgery at UCSF found that prior GLP-1 receptor agonist use was not…
A reanalysis of Sweden’s population-based colorectal cancer screening program suggests that the mortality benefit of fecal occult blood testing (FOBT)…
The 13-year follow-up of the NORDICC randomized trial found that a single screening colonoscopy reduced colorectal cancer incidence but did…
A reanalysis of Sweden’s population-based fecal occult blood test (FOBT) screening program suggests that the mortality benefit of colorectal cancer…